eli lilly and company retatrutide Lillys what is it: Detailed Information for Patients Lilly's Retatrutide Continues To Show

Cell Mol Biol Lett 10: 255-264

And vice versa: If you take GLP-1 agonists, you shouldnt try to get pregnant

Warnings and Precautions 5.1 Risk of Thyroid C-Cell Tumors In mice and rats, semaglutide caused a dose-dependent and treatment-duration-dependent increase in the incidence of thyroid C-cell tumors (adenomas and carcinomas) after lifetime exposure at clinically relevant plasma exposures [see Nonclinical Toxicology (13.1)]

[6] Regulatory bodies including the MHRA and EMA have included pancreatitis as a potential adverse effect in the prescribing information for GLP-1 agonists

Systemic bioavailability with standard oral forms is very low Oral vs